Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference

Rhea-AI Summary

Harvard Bioscience announced that its CEO, Jim Green, and CFO, Jennifer Cote, will participate in the Benchmark Healthcare House Call Virtual Conference on May 22, 2024. The event will feature a live fireside chat from 9:00-9:40 am ET and one-on-one meetings with investors. Interested parties can register for the presentation or schedule meetings via the Benchmark website.

Positive

• CEO and CFO participation in a notable conference may increase investor interest and visibility.
• Opportunity for one-on-one meetings could foster investor relations and potential investments.

Negative

• No new financial or clinical data was provided in the announcement.
• Potential lack of significant developments that could positively impact stock performance.

HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22^nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET. The Company will also be hosting one-on-one meetings with investors in conjunction with the Conference.

To register for the presentation, or to schedule a one-on-one meeting, please visit the Benchmark website at 2024 Benchmark Healthcare House Call Virtual Conference.

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.  For more information, please visit our website at www.harvardbioscience.com

Company Contact:
Harvard Bioscience
Jennifer Cote, Chief Financial Officer
(508) 893-3120

Investor Contacts:
Three Part Advisors
Sandy Martin / Erol Girgin / William Shelmire
HBIO@threepa.com
(214) 616-2207 

FAQ

When will Harvard Bioscience participate in the Benchmark Healthcare House Call Virtual Conference?

Harvard Bioscience will participate on May 22, 2024.

What time is the live fireside chat for Harvard Bioscience at the Benchmark Conference?

The live fireside chat is scheduled from 9:00-9:40 am ET on May 22, 2024.

Who from Harvard Bioscience will be presenting at the Benchmark Healthcare House Call Virtual Conference?

Jim Green, CEO, and Jennifer Cote, CFO, will be presenting.

Can investors schedule one-on-one meetings with Harvard Bioscience during the Benchmark Conference?

Yes, one-on-one meetings with investors can be scheduled.

How can one register for Harvard Bioscience's presentation at the Benchmark Conference?

Registration can be done via the Benchmark website.